Story perspectives

NICE Approves Fezolinetant for Menopausal Symptoms Relief

3/13/2026

Summary

Story summary

The National Institute for Health and Care Excellence (NICE) has recommended fezolinetant (Veoza) as a non-hormonal treatment for menopausal hot flushes and night sweats.
This once-daily tablet is intended for women unable to take hormone replacement therapy (HRT) due to medical conditions, such as a history of deep vein thrombosis.
NICE's guidance states that fezolinetant can significantly reduce symptoms and improve quality of life, although there is some uncertainty about its exact benefits.
Common side effects include abdominal pain and insomnia.

1 of 1

Story summary

The National Institute for Health and Care Excellence (NICE) has recommended fezolinetant (Veoza) as a non-hormonal treatment for menopausal hot flushes and night sweats.
This once-daily tablet is intended for women unable to take hormone replacement therapy (HRT) due to medical conditions, such as a history of deep vein thrombosis.
NICE's guidance states that fezolinetant can significantly reduce symptoms and improve quality of life, although there is some uncertainty about its exact benefits.
Common side effects include abdominal pain and insomnia.